ウルソデオキシコール酸API市場レポート：2031年までの動向、予測、競合分析

世界のウルソデオキシコール酸API市場の将来性は、薬局と健康製品市場での機会で有望視されています。世界のウルソデオキシコール酸API市場は、2025年から2031年にかけて11.2％のCAGRで成長すると予想されています。この市場の主な促進要因は、肝臓疾患の有病率の増加、胆石治療のためのウルソデオキシコール酸の採用率の上昇、ヘルスケア支出の増加です。

• Lucintelの予測では、製品タイプ別では、合成UDCAは大量生産が可能なため、予測期間中に高い成長が見込まれます。
• 用途別では、肝疾患治療への需要の高まりから、薬局が高い成長を遂げると予想されています。
• 地域別では、ヘルスケア投資の増加によりAPACが予測期間中最も高い成長が見込まれています。

ウルソデオキシコール酸API市場の新たな動向

肝疾患治療に対する需要の絶え間ない変化、製薬技術の成長、持続可能な製造に向けた動きは、業界の仕組みを変えつつあり、ウルソデオキシコール酸API市場もその流れから外れていないです。そこで、市場に影響を与える5つの動向を見てみよう。

• イノベーション・アームの目覚ましい成長：ウルソデオキシコール酸の既存用途に対する研究開発のイノベーション・タワーは以前より広くなっています。例えば、生産者はNAFLDだけでなく、肝線維症も肝疾患リストに含めています。これは、ウルソデオキシコール酸の新しい製剤の創出、ひいては新たな事業拡大に向けた競合を刺激する現象です。研究開発システムへのさらなる統合は、ウルソデオキシコール酸原薬を他の肝疾患に使用されるものと差別化し、患者の治療成績を向上させるために有益であろう。
• 製造における持続可能性：環境に優しい製法を求める市場は拡大しており、ウルソデオキシコール酸原薬の製造も同様です。製造業者は、廃棄物の最小化、水の節約、二酸化炭素排出量の削減など、環境悪化の影響の少ないグリーン技術を採用しています。製薬業界でも、持続可能な生産が注目されています。環境に配慮した製法に対する規制当局の要求や消費者の期待が高まる中、ウルソデオキシコール酸メーカーも動向に合わせて動かざるを得ないです。
• 製剤の進歩：徐放性・徐放性ウルソデオキシコール酸製剤のような新しい洗練された製剤の導入は、業界の新しい動向を示すものです。このような製剤は、患者が治療を遵守する上でより効果的であるだけでなく、治療上もより効果的です。肝疾患治療の改善もまた、ウルソデオキシコール酸原薬生産者にとって、ターゲットを絞ったドラッグデリバリーの大きな可能性を約束しています。
• 新興地域からの需要の増加：インド、中国、東南アジアのような市場における肝臓疾患の有病率の上昇ペースは、ウルソデオキシコール酸原薬の需要を押し上げています。ヘルスケアのインフラが整備され、肝疾患の治療を求める人が増えているため、手頃な価格で効果的な治療法のニーズが高まっています。製造業者は、これらの市場における需要の高まりに対応するため、ウルソデオキシコール酸原薬を低価格で製造することに重点を移しており、それによって市場の成長を促進しています。
• 肝疾患治療に関する有利な規制：多くの国々が、肝疾患治療薬の研究開発・認可を支援する目的で、市場にとって友好的な政策を確立・実施しようとしています。各国政府や規制当局は、ウルソデオキシコール酸のような医薬品にインセンティブを与え、迅速な承認を提供することで、肝疾患の世界の負担の増加に対応しています。この現象は、いくつかの市場でウルソデオキシコール酸原薬の迅速な流通を助け、メーカーを助けています。

研究開発への注力、持続可能性、洗練された薬剤処方、ウルソデオキシコール酸原薬による新たな市場牽引力、有利な政策設定を含むこれらの新たな動向は、メーカーに課題とともに新たな機会を提供することで、ウルソデオキシコール酸原薬市場を変革しています。このシフトは、より持続可能で、革新的で、患者中心のエンゲージメント・ソリューションへと成長を推し進める可能性が高いです。

ウルソデオキシコール酸API市場の最近の動向

ウルソデオキシコール酸（ursodeoxycholic acid）原薬市場には、現在および将来の展望に影響を与える顕著な変化があります。これらの変化は、技術の向上、政策の変更、ウルソデオキシコール酸の他の潜在的な治療用途に関する調査への注目の高まりによるものです。以下に注目すべき5つの変化を挙げる：

• 生産技術の進歩：製造技術の進歩：製造業におけるより良い製造方法の採用も、ウルソデオキシコール酸API市場を後押ししています。連続製造やその他の高度な精製方法など、製造工程における自動化技術の導入により、高品質でありながら低コストのウルソデオキシコール酸原薬が生産されるようになりました。これらの開発により、生産者は国際的な需要の増加に対応しながら、世界の品質基準を維持することができるようになりました。
• 非アルコール性脂肪性肝炎（NASH）への注目：非アルコール性脂肪性肝炎（NASH）やその他の肝疾患に対するアンメットニーズは、製薬会社による研究開発への公的・民間両部門の支出の増加によって高まっています。NASHやB型肝炎などの治療におけるウルソデオキシコール酸の可能性を探ることに、ますます注目が集まっています。研究開発への取り組みが進むにつれて、原薬の需要とともにウルソデオキシコール酸の使用範囲も拡大すると予想されます。
• 既存薬使用の新規承認：既存薬の新たな用途の承認を可能にする規制は、ウルソデオキシコール酸をベースとした製品の市場における進歩を際立たせています。ウルソデオキシコール酸をより広い範囲の肝疾患の治療に使用することが当局から認められ、治療範囲が広がっています。ウルソデオキシコール酸製剤の市場開拓を加速させるため、各社はウルソデオキシコール酸製剤の開発に取り組んでいます。
• さらに環境にやさしい生産への取り組み：ウルソデオキシコール酸原薬メーカーの中には、環境に配慮し、規制当局が注目する中、より環境的に持続可能な方法で生産を開始する企業も増えてきています。このような行動には、廃棄物の量を減らすこと、エネルギー戦略をより効率的なものに変えること、化学工程でより少ない有害物質を使用することなどが含まれます。このような活動により、ウルソデオキシコール酸原薬メーカーは環境保護に貢献し、持続可能性に関する様々な国際基準を満たすことができます。
• コラボレーションによる市場拡大：他の市場と同様、ウルソデオキシコール酸原薬事業においても、製薬会社と研究開発機関との戦略的提携が次第に重要になってきています。このような提携は、ウルソデオキシコール酸の新しい製剤や治療用途の創出における相乗効果の強化を促進します。同時に、このような提携はウルソデオキシコール酸原薬の国際的な流通を改善し、より多くの新興諸国での利用を可能にしています。

強化された技術、研究開発への投資拡大、助成金、持続可能性対策などの側面が、UCDAのAPI市場には前向きな方向性を示しています。イノベーション、業務効率化、新たな治療適応症の創出は、このような現象を利用し、増加する世界のニーズを満たすためにメーカーが注力していることです。

目次

第1章 エグゼクティブサマリー

第2章 市場概要

• 背景と分類
• サプライチェーン

第3章 市場動向と予測分析

• マクロ経済の動向と予測
• 業界の促進要因と課題
• PESTLE分析
• 特許分析
• 規制環境

第4章 ウルソデオキシコール酸API市場：タイプ別

• 概要
• タイプ別魅力分析
• 合成UDCA：動向と予測（2019年～2031年）
• 抽出UDCA：動向と予測（2019年～2031年）

第5章 ウルソデオキシコール酸API市場：用途別

• 概要
• 用途別魅力分析
• 薬学：動向と予測（2019年～2031年）
• 健康製品：動向と予測（2019年～2031年）

第6章 地域分析

• 概要
• 地域別ウルソデオキシコール酸API市場

第7章 北米のウルソデオキシコール酸API市場

• 概要
• 北米ウルソデオキシコール酸API市場、タイプ別
• 北米のウルソデオキシコール酸API市場、用途別
• 米国のウルソデオキシコール酸API市場
• メキシコのウルソデオキシコール酸API市場
• カナダのウルソデオキシコール酸API市場

第8章 欧州のウルソデオキシコール酸API市場

• 概要
• 欧州のウルソデオキシコール酸API市場、タイプ別
• 欧州のウルソデオキシコール酸API市場、用途別
• ドイツのウルソデオキシコール酸API市場
• フランスのウルソデオキシコール酸API市場
• スペインのウルソデオキシコール酸API市場
• イタリアのウルソデオキシコール酸API市場
• 英国のウルソデオキシコール酸API市場

第9章 アジア太平洋のウルソデオキシコール酸API市場

• 概要
• アジア太平洋のウルソデオキシコール酸API市場、タイプ別
• アジア太平洋のウルソデオキシコール酸API市場、用途別
• 日本のウルソデオキシコール酸API市場
• インドのウルソデオキシコール酸API市場
• 中国のウルソデオキシコール酸API市場
• 韓国のウルソデオキシコール酸API市場
• インドネシアのウルソデオキシコール酸API市場

第10章 その他地域のウルソデオキシコール酸API市場

• 概要
• その他地域のウルソデオキシコール酸API市場、タイプ別
• その他地域のウルソデオキシコール酸API市場、用途別
• 中東のウルソデオキシコール酸API市場
• 南米のウルソデオキシコール酸API市場
• アフリカのウルソデオキシコール酸API市場

第11章 競合分析

• 製品ポートフォリオ分析
• 運用統合
• ポーターのファイブフォース分析
  • 競争企業間の敵対関係
  • 買い手の交渉力
  • 供給企業の交渉力
  • 代替品の脅威
  • 新規参入業者の脅威
• 市場シェア分析

第12章 機会と戦略分析

• バリューチェーン分析
• 成長機会分析
  • タイプ別の成長機会
  • 用途別の成長機会
• ウルソデオキシコール酸API市場の新たな動向
• 戦略分析
  • 新製品開発
  • 認証とライセンシング
  • 合併、買収、契約、提携、合弁事業

第13章 バリューチェーンにおける主要企業の企業プロファイル

• Competitive Analysis
• ICE
• Mitsubishi Tanabe Pharma
• Daewoong Chemical
• PharmaZell
• Zhongshan Bailing
• Dipharma Francis
• Grindeks

第14章 付録

• 図表一覧
• 表の一覧
• 調査手法
• 免責事項
• 著作権
• 略語と技術単位
• 当社について
• 問い合わせ

List of Figures

• Figure 1.1: Trends and Forecast for the Global Ursodeoxycholic Acid API Market
• Figure 2.1: Usage of Ursodeoxycholic Acid API Market
• Figure 2.2: Classification of the Global Ursodeoxycholic Acid API Market
• Figure 2.3: Supply Chain of the Global Ursodeoxycholic Acid API Market
• Figure 2.4: Driver and Challenges of the Ursodeoxycholic Acid API Market
• Figure 3.1: Trends of the Global GDP Growth Rate
• Figure 3.2: Trends of the Global Population Growth Rate
• Figure 3.3: Trends of the Global Inflation Rate
• Figure 3.4: Trends of the Global Unemployment Rate
• Figure 3.5: Trends of the Regional GDP Growth Rate
• Figure 3.6: Trends of the Regional Population Growth Rate
• Figure 3.7: Trends of the Regional Inflation Rate
• Figure 3.8: Trends of the Regional Unemployment Rate
• Figure 3.9: Trends of Regional Per Capita Income
• Figure 3.10: Forecast for the Global GDP Growth Rate
• Figure 3.11: Forecast for the Global Population Growth Rate
• Figure 3.12: Forecast for the Global Inflation Rate
• Figure 3.13: Forecast for the Global Unemployment Rate
• Figure 3.14: Forecast for the Regional GDP Growth Rate
• Figure 3.15: Forecast for the Regional Population Growth Rate
• Figure 3.16: Forecast for the Regional Inflation Rate
• Figure 3.17: Forecast for the Regional Unemployment Rate
• Figure 3.18: Forecast for Regional Per Capita Income
• Figure 4.1: Global Ursodeoxycholic Acid API Market by Type in 2019, 2024, and 2031
• Figure 4.2: Trends of the Global Ursodeoxycholic Acid API Market ($B) by Type
• Figure 4.3: Forecast for the Global Ursodeoxycholic Acid API Market ($B) by Type
• Figure 4.4: Trends and Forecast for Synthetic UDCA in the Global Ursodeoxycholic Acid API Market (2019-2031)
• Figure 4.5: Trends and Forecast for Extraction UDCA in the Global Ursodeoxycholic Acid API Market (2019-2031)
• Figure 5.1: Global Ursodeoxycholic Acid API Market by Application in 2019, 2024, and 2031
• Figure 5.2: Trends of the Global Ursodeoxycholic Acid API Market ($B) by Application
• Figure 5.3: Forecast for the Global Ursodeoxycholic Acid API Market ($B) by Application
• Figure 5.4: Trends and Forecast for Pharmacy in the Global Ursodeoxycholic Acid API Market (2019-2031)
• Figure 5.5: Trends and Forecast for Health Products in the Global Ursodeoxycholic Acid API Market (2019-2031)
• Figure 6.1: Trends of the Global Ursodeoxycholic Acid API Market ($B) by Region (2019-2024)
• Figure 6.2: Forecast for the Global Ursodeoxycholic Acid API Market ($B) by Region (2025-2031)
• Figure 7.1: Trends and Forecast for the North American Ursodeoxycholic Acid API Market (2019-2031)
• Figure 7.2: North American Ursodeoxycholic Acid API Market by Type in 2019, 2024, and 2031
• Figure 7.3: Trends of the North American Ursodeoxycholic Acid API Market ($B) by Type (2019-2024)
• Figure 7.4: Forecast for the North American Ursodeoxycholic Acid API Market ($B) by Type (2025-2031)
• Figure 7.5: North American Ursodeoxycholic Acid API Market by Application in 2019, 2024, and 2031
• Figure 7.6: Trends of the North American Ursodeoxycholic Acid API Market ($B) by Application (2019-2024)
• Figure 7.7: Forecast for the North American Ursodeoxycholic Acid API Market ($B) by Application (2025-2031)
• Figure 7.8: Trends and Forecast for the United States Ursodeoxycholic Acid API Market ($B) (2019-2031)
• Figure 7.9: Trends and Forecast for the Mexican Ursodeoxycholic Acid API Market ($B) (2019-2031)
• Figure 7.10: Trends and Forecast for the Canadian Ursodeoxycholic Acid API Market ($B) (2019-2031)
• Figure 8.1: Trends and Forecast for the European Ursodeoxycholic Acid API Market (2019-2031)
• Figure 8.2: European Ursodeoxycholic Acid API Market by Type in 2019, 2024, and 2031
• Figure 8.3: Trends of the European Ursodeoxycholic Acid API Market ($B) by Type (2019-2024)
• Figure 8.4: Forecast for the European Ursodeoxycholic Acid API Market ($B) by Type (2025-2031)
• Figure 8.5: European Ursodeoxycholic Acid API Market by Application in 2019, 2024, and 2031
• Figure 8.6: Trends of the European Ursodeoxycholic Acid API Market ($B) by Application (2019-2024)
• Figure 8.7: Forecast for the European Ursodeoxycholic Acid API Market ($B) by Application (2025-2031)
• Figure 8.8: Trends and Forecast for the German Ursodeoxycholic Acid API Market ($B) (2019-2031)
• Figure 8.9: Trends and Forecast for the French Ursodeoxycholic Acid API Market ($B) (2019-2031)
• Figure 8.10: Trends and Forecast for the Spanish Ursodeoxycholic Acid API Market ($B) (2019-2031)
• Figure 8.11: Trends and Forecast for the Italian Ursodeoxycholic Acid API Market ($B) (2019-2031)
• Figure 8.12: Trends and Forecast for the United Kingdom Ursodeoxycholic Acid API Market ($B) (2019-2031)
• Figure 9.1: Trends and Forecast for the APAC Ursodeoxycholic Acid API Market (2019-2031)
• Figure 9.2: APAC Ursodeoxycholic Acid API Market by Type in 2019, 2024, and 2031
• Figure 9.3: Trends of the APAC Ursodeoxycholic Acid API Market ($B) by Type (2019-2024)
• Figure 9.4: Forecast for the APAC Ursodeoxycholic Acid API Market ($B) by Type (2025-2031)
• Figure 9.5: APAC Ursodeoxycholic Acid API Market by Application in 2019, 2024, and 2031
• Figure 9.6: Trends of the APAC Ursodeoxycholic Acid API Market ($B) by Application (2019-2024)
• Figure 9.7: Forecast for the APAC Ursodeoxycholic Acid API Market ($B) by Application (2025-2031)
• Figure 9.8: Trends and Forecast for the Japanese Ursodeoxycholic Acid API Market ($B) (2019-2031)
• Figure 9.9: Trends and Forecast for the Indian Ursodeoxycholic Acid API Market ($B) (2019-2031)
• Figure 9.10: Trends and Forecast for the Chinese Ursodeoxycholic Acid API Market ($B) (2019-2031)
• Figure 9.11: Trends and Forecast for the South Korean Ursodeoxycholic Acid API Market ($B) (2019-2031)
• Figure 9.12: Trends and Forecast for the Indonesian Ursodeoxycholic Acid API Market ($B) (2019-2031)
• Figure 10.1: Trends and Forecast for the ROW Ursodeoxycholic Acid API Market (2019-2031)
• Figure 10.2: ROW Ursodeoxycholic Acid API Market by Type in 2019, 2024, and 2031
• Figure 10.3: Trends of the ROW Ursodeoxycholic Acid API Market ($B) by Type (2019-2024)
• Figure 10.4: Forecast for the ROW Ursodeoxycholic Acid API Market ($B) by Type (2025-2031)
• Figure 10.5: ROW Ursodeoxycholic Acid API Market by Application in 2019, 2024, and 2031
• Figure 10.6: Trends of the ROW Ursodeoxycholic Acid API Market ($B) by Application (2019-2024)
• Figure 10.7: Forecast for the ROW Ursodeoxycholic Acid API Market ($B) by Application (2025-2031)
• Figure 10.8: Trends and Forecast for the Middle Eastern Ursodeoxycholic Acid API Market ($B) (2019-2031)
• Figure 10.9: Trends and Forecast for the South American Ursodeoxycholic Acid API Market ($B) (2019-2031)
• Figure 10.10: Trends and Forecast for the African Ursodeoxycholic Acid API Market ($B) (2019-2031)
• Figure 11.1: Porter's Five Forces Analysis of the Global Ursodeoxycholic Acid API Market
• Figure 11.2: Market Share (%) of Top Players in the Global Ursodeoxycholic Acid API Market (2024)
• Figure 12.1: Growth Opportunities for the Global Ursodeoxycholic Acid API Market by Type
• Figure 12.2: Growth Opportunities for the Global Ursodeoxycholic Acid API Market by Application
• Figure 12.3: Growth Opportunities for the Global Ursodeoxycholic Acid API Market by Region
• Figure 12.4: Emerging Trends in the Global Ursodeoxycholic Acid API Market

List of Tables

• Table 1.1: Growth Rate (%, 2023-2024) and CAGR (%, 2025-2031) of the Ursodeoxycholic Acid API Market by Type and Application
• Table 1.2: Attractiveness Analysis for the Ursodeoxycholic Acid API Market by Region
• Table 1.3: Global Ursodeoxycholic Acid API Market Parameters and Attributes
• Table 3.1: Trends of the Global Ursodeoxycholic Acid API Market (2019-2024)
• Table 3.2: Forecast for the Global Ursodeoxycholic Acid API Market (2025-2031)
• Table 4.1: Attractiveness Analysis for the Global Ursodeoxycholic Acid API Market by Type
• Table 4.2: Market Size and CAGR of Various Type in the Global Ursodeoxycholic Acid API Market (2019-2024)
• Table 4.3: Market Size and CAGR of Various Type in the Global Ursodeoxycholic Acid API Market (2025-2031)
• Table 4.4: Trends of Synthetic UDCA in the Global Ursodeoxycholic Acid API Market (2019-2024)
• Table 4.5: Forecast for Synthetic UDCA in the Global Ursodeoxycholic Acid API Market (2025-2031)
• Table 4.6: Trends of Extraction UDCA in the Global Ursodeoxycholic Acid API Market (2019-2024)
• Table 4.7: Forecast for Extraction UDCA in the Global Ursodeoxycholic Acid API Market (2025-2031)
• Table 5.1: Attractiveness Analysis for the Global Ursodeoxycholic Acid API Market by Application
• Table 5.2: Market Size and CAGR of Various Application in the Global Ursodeoxycholic Acid API Market (2019-2024)
• Table 5.3: Market Size and CAGR of Various Application in the Global Ursodeoxycholic Acid API Market (2025-2031)
• Table 5.4: Trends of Pharmacy in the Global Ursodeoxycholic Acid API Market (2019-2024)
• Table 5.5: Forecast for Pharmacy in the Global Ursodeoxycholic Acid API Market (2025-2031)
• Table 5.6: Trends of Health Products in the Global Ursodeoxycholic Acid API Market (2019-2024)
• Table 5.7: Forecast for Health Products in the Global Ursodeoxycholic Acid API Market (2025-2031)
• Table 6.1: Market Size and CAGR of Various Regions in the Global Ursodeoxycholic Acid API Market (2019-2024)
• Table 6.2: Market Size and CAGR of Various Regions in the Global Ursodeoxycholic Acid API Market (2025-2031)
• Table 7.1: Trends of the North American Ursodeoxycholic Acid API Market (2019-2024)
• Table 7.2: Forecast for the North American Ursodeoxycholic Acid API Market (2025-2031)
• Table 7.3: Market Size and CAGR of Various Type in the North American Ursodeoxycholic Acid API Market (2019-2024)
• Table 7.4: Market Size and CAGR of Various Type in the North American Ursodeoxycholic Acid API Market (2025-2031)
• Table 7.5: Market Size and CAGR of Various Application in the North American Ursodeoxycholic Acid API Market (2019-2024)
• Table 7.6: Market Size and CAGR of Various Application in the North American Ursodeoxycholic Acid API Market (2025-2031)
• Table 7.7: Trends and Forecast for the United States Ursodeoxycholic Acid API Market (2019-2031)
• Table 7.8: Trends and Forecast for the Mexican Ursodeoxycholic Acid API Market (2019-2031)
• Table 7.9: Trends and Forecast for the Canadian Ursodeoxycholic Acid API Market (2019-2031)
• Table 8.1: Trends of the European Ursodeoxycholic Acid API Market (2019-2024)
• Table 8.2: Forecast for the European Ursodeoxycholic Acid API Market (2025-2031)
• Table 8.3: Market Size and CAGR of Various Type in the European Ursodeoxycholic Acid API Market (2019-2024)
• Table 8.4: Market Size and CAGR of Various Type in the European Ursodeoxycholic Acid API Market (2025-2031)
• Table 8.5: Market Size and CAGR of Various Application in the European Ursodeoxycholic Acid API Market (2019-2024)
• Table 8.6: Market Size and CAGR of Various Application in the European Ursodeoxycholic Acid API Market (2025-2031)
• Table 8.7: Trends and Forecast for the German Ursodeoxycholic Acid API Market (2019-2031)
• Table 8.8: Trends and Forecast for the French Ursodeoxycholic Acid API Market (2019-2031)
• Table 8.9: Trends and Forecast for the Spanish Ursodeoxycholic Acid API Market (2019-2031)
• Table 8.10: Trends and Forecast for the Italian Ursodeoxycholic Acid API Market (2019-2031)
• Table 8.11: Trends and Forecast for the United Kingdom Ursodeoxycholic Acid API Market (2019-2031)
• Table 9.1: Trends of the APAC Ursodeoxycholic Acid API Market (2019-2024)
• Table 9.2: Forecast for the APAC Ursodeoxycholic Acid API Market (2025-2031)
• Table 9.3: Market Size and CAGR of Various Type in the APAC Ursodeoxycholic Acid API Market (2019-2024)
• Table 9.4: Market Size and CAGR of Various Type in the APAC Ursodeoxycholic Acid API Market (2025-2031)
• Table 9.5: Market Size and CAGR of Various Application in the APAC Ursodeoxycholic Acid API Market (2019-2024)
• Table 9.6: Market Size and CAGR of Various Application in the APAC Ursodeoxycholic Acid API Market (2025-2031)
• Table 9.7: Trends and Forecast for the Japanese Ursodeoxycholic Acid API Market (2019-2031)
• Table 9.8: Trends and Forecast for the Indian Ursodeoxycholic Acid API Market (2019-2031)
• Table 9.9: Trends and Forecast for the Chinese Ursodeoxycholic Acid API Market (2019-2031)
• Table 9.10: Trends and Forecast for the South Korean Ursodeoxycholic Acid API Market (2019-2031)
• Table 9.11: Trends and Forecast for the Indonesian Ursodeoxycholic Acid API Market (2019-2031)
• Table 10.1: Trends of the ROW Ursodeoxycholic Acid API Market (2019-2024)
• Table 10.2: Forecast for the ROW Ursodeoxycholic Acid API Market (2025-2031)
• Table 10.3: Market Size and CAGR of Various Type in the ROW Ursodeoxycholic Acid API Market (2019-2024)
• Table 10.4: Market Size and CAGR of Various Type in the ROW Ursodeoxycholic Acid API Market (2025-2031)
• Table 10.5: Market Size and CAGR of Various Application in the ROW Ursodeoxycholic Acid API Market (2019-2024)
• Table 10.6: Market Size and CAGR of Various Application in the ROW Ursodeoxycholic Acid API Market (2025-2031)
• Table 10.7: Trends and Forecast for the Middle Eastern Ursodeoxycholic Acid API Market (2019-2031)
• Table 10.8: Trends and Forecast for the South American Ursodeoxycholic Acid API Market (2019-2031)
• Table 10.9: Trends and Forecast for the African Ursodeoxycholic Acid API Market (2019-2031)
• Table 11.1: Product Mapping of Ursodeoxycholic Acid API Suppliers Based on Segments
• Table 11.2: Operational Integration of Ursodeoxycholic Acid API Manufacturers
• Table 11.3: Rankings of Suppliers Based on Ursodeoxycholic Acid API Revenue
• Table 12.1: New Product Launches by Major Ursodeoxycholic Acid API Producers (2019-2024)
• Table 12.2: Certification Acquired by Major Competitor in the Global Ursodeoxycholic Acid API Market

The future of the global ursodeoxycholic acid API market looks promising with opportunities in the pharmacy and health product markets. The global ursodeoxycholic acid API market is expected to grow with a CAGR of 11.2% from 2025 to 2031. The major drivers for this market are the increasing prevalence of liver diseases, the rising adoption of ursodeoxycholic acid for treating gallstones, and the growing healthcare spending.

• Lucintel forecasts that, within the type category, synthetic UDCA is expected to witness higher growth over the forecast period due to its large-scale production.
• Within the application category, pharmacy is expected to witness higher growth due to the increasing demand for liver disease treatments.
• In terms of region, APAC is expected to witness the highest growth over the forecast period due to the rising healthcare investments.

Emerging Trends in the Ursodeoxycholic Acid API Market

The constant changes in the demand for liver disease treatments, the growth of pharmaceutical technology, and the movement toward sustainable manufacturing are shifting how the industry works, and the ursodeoxycholic acid API market is not off the hook either. Given these observations, take a look at five trends affecting the market.

• Alarming Growth in the Innovation Arms: The innovation towers of R&D for the existing application of ursodeoxycholic acid are wider than before. For example, the producers are looking beyond NAFLD and include hepatic fibrosis in the liver disease list. This constitutes a phenomenon that stimulates competition toward the creation of new formulations of ursodeoxycholic acid and hence new business expansions. Further integration into the R&D systems will be beneficial for the differentiation of the ursodeoxycholic acid APIs from those used in other liver disorders and for the enhancement of treatment outcomes for patients.
• Sustainability in Manufacturing: There is a growing market with a demand for eco-friendly practices, and the production of ursodeoxycholic acid APIs is no different. Manufacturers are adopting green technologies that have less of an environmentally degrading effect, including waste minimization, water conservation, and reduction of carbon emissions. Even in the pharmaceutical industry, sustainable production is being given a lot of attention. With regulatory demands and consumer expectations for environmentally friendly practices, ursodeoxycholic acid manufacturers have no option but to move with the trends.
• Advancements in Drug Formulations: The introduction of new sophisticated drug formulations like slow-release and sustained-release ursodeoxycholic acid-based drugs is a mark of the new trend of the industry. Such drug formulations would not only be more effective in enabling patients to comply with treatment but also more effective therapeutically. Improvements in liver disease treatment also provide great potential for targeted drug delivery promises for ursodeoxycholic acid API producers.
• Increased Demand from Emerging Regions: The pace rising prevalence of liver diseases in markets like India, China, and Southeast Asia is boosting the demand for ursodeoxycholic acid APIs. With the improvement in healthcare infrastructure and an increasing number of individuals seeking treatment for liver disorders, the need for affordable and effective therapies is on the rise. Manufacturers are shifting their focus to produce ursodeoxycholic acid APIs at lower prices to meet the rising demand in these markets, thereby propelling the growth of the market.
• Favorable Regulations about Liver Disease Treatment: A number of countries are trying to establish and implement policies that are friendly for the market in the purpose or aid the research, development, and approval of new liver disease treatment options. Governments and regulators have responded to the increase in the global burden of liver diseases by incentivizing and providing fast-track approval for drugs like ursodeoxycholic acid. This phenomenon is assisting in the rapid distribution of ursodeoxycholic acid APIs in several markets, which helps the manufacturers.

These emerging trends, which include R&D focus, sustainability, sophisticated drug formulation, new market drives from ursodeoxycholic acid APIs, and favorable policy setup, are transforming the ursodeoxycholic acid API market by providing new opportunities along with challenges to the manufacturers. The shifts are likely to push growth towards more sustainable, innovative, and patient-centric engagement solutions.

Recent Developments in the Ursodeoxycholic Acid API Market

There are notable changes in the market for Active Pharmaceutical Ingredient of Ursodeoxycholic Acid (ursodeoxycholic acid) that are affecting its present and future landscape. These changes are due to improved technology, changes in policies, and increased focus on research regarding other potential therapeutic uses of ursodeoxycholic acid. Given below are five notable changes:

• Advances in Production Technology: Adoption of better production methods in manufacturing industries is also helping the ursodeoxycholic acid API market. The introduction of automated techniques in production processes, like continuous manufacturing and other advanced methods of purification, has produced high-quality, but low-cost ursodeoxycholic acid APIs. These developments have allowed producers to maintain the growing global quality standards while meeting the increasing international demand.
• Focus on Non-Alcoholic Steatohepatitis (NASH): The increased spending both in public and private sectors on research and development by pharmaceutical companies is fueling the unmet needs of nonalcoholic steatohepatitis (NASH) and other liver diseases. There is an increasing focus on exploring the potential of ursodeoxycholic acid for treating conditions like NASH and hepatitis B. It is anticipated that with the increasing efforts in research and development, the scope of usage for ursodeoxycholic acid will increase along with the demand for its APIs.
• New Approval for Using Existing Drugs: The regulations that allow for the approval of new uses for existing drugs highlight the progress made in the market for ursodeoxycholic acid-based products. The use of ursodeoxycholic acid for the treatment of a wider scope of liver diseases is being granted by the governing authorities, which is broadening its therapeutic scope. With attempts by marketing ursodeoxycholic acid-based products, the companies are trying to comply with them so that they can accelerate the development of new formulations of ursodeoxycholic acid drugs.
• Efforts Towards Even More Environmentally Friendly Production: There is an increasing number of ursodeoxycholic acid API manufacturers that, in light of heightened eco-friendly concern and regulatory attention, have started to produce in a more environmentally sustainable manner. Such actions may involve decreasing the amount of waste, changing energy strategies to more efficient ones, and using less hazardous substances for the chemical processes. These activities will allow the manufacturers of the ursodeoxycholic acid API to contribute to the care of the environment and help them meet various international standards of sustainability.
• Market Expansion through Collaborations: As it is in other markets, the strategic partnering of pharmaceutical firms with research and development institutions has been progressively more important in the ursodeoxycholic acid API business. Such collaborations facilitate the consolidation of synergies in the creation of new formulations and therapeutic uses of ursodeoxycholic acid. At the same time, these collaborations are improving the international distribution of ursodeoxycholic acid APIs to make them available in more developing countries.

Aspects such as enhanced technologies, growing investments into R&D, grants, and sustainability measures are UCDA API market forces looking in the forward direction. Innovation, operating efficiency, and creating new therapeutic indications are the focuses of the manufacturers to take advantage of the phenomena and satisfy the increasing global needs.

Strategic Growth Opportunities in the Ursodeoxycholic Acid API Market

Several strategic growth prospects exist in the application of the ursodeoxycholic acid API, which is simultaneously and operationally utilized in different spheres. The same is augmented due to the increased need for liver disease treatments, technological innovations, and growth of other pharmaceutical markets. These include but are not limited to these five opportunities:

• Increasing Application in Liver Disease Conditions: With the increase in the number of people suffering from liver diseases, there is a great potential for improvement of ursodeoxycholic acid APIs in PBC, fatty liver disease, and cirrhosis. As the focus on the management of liver diseases increases, there is a corresponding increase in the need for drugs based on ursodeoxycholic acid. Hence, this factor largely increases the growth of UDC APIs.
• Concentrating on Emerging Markets: Ursodeoxycholic acid API producers stand to gain enormously from newly industrialized regions in Asia and Africa. The demand for affordable treatment options is estimated to rise as the healthcare infrastructure improves and there is an increase in the awareness of liver diseases. To serve these emerging markets, manufacturers are looking to provide cost-effective ursodeoxycholic acid APIs.
• Tackling Non-Alcoholic Fatty Liver Disease (NAFLD): The rising obesity rates and the growing occurrence of NAFLD is a huge opportunity for the growth of ursodeoxycholic acid APIs. There are ongoing studies that aim to assess the efficacy of ursodeoxycholic acid in the treatment of NAFLD, and with the advancement of clinical trials, this could possibly create a new market segment for drugs based on ursodeoxycholic acid.
• Innovative Systems of Drug Delivery: The development of new systems of drug delivery, particularly sustained release and oral dosage forms, provides a unique opportunity for growth with ursodeoxycholic acid APIs. Increased patient adherence coupled with improved therapeutic efficacy from these systems will undoubtedly increase the use of ursodeoxycholic acid-based treatments.
• Market Expansion by Collaboration and Partnerships: The merging of manufacturers, research centers, and healthcare facilities allows for the strategic marketing of the ursodeoxycholic acid API on an international scale. Involving other stakeholders in the pharmaceutical supply chain facilitates manufacturers in product development, distribution, and access to international markets.

These partnerships along with innovations in drug delivery, treatment expansion in emerging markets, and focus on NAFLD, offer the strategic growth opportunities that are likely to foster the future of the ursodeoxycholic acid API market. Those manufacturers who pursue them will reap the benefits of a well-established position in the long term.

Ursodeoxycholic Acid API Market Driver and Challenges

Like many other markets, the ursodeoxycholic acid API market is being driven and challenged by many factors which influence its growth. Also featured are new technological developments, increasing treatment needs for liver diseases, and the many facets of liver disease regulatory scope. Five drivers and three different challenges are provided below.

The factors responsible for driving the ursodeoxycholic acid API market include:

1. Rising Prevalence of Liver Diseases: Cirrhosis, NAFLD, PBC, and other liver disorders and their increasing prevalence globally is one of the key drivers of the ursodeoxycholic acid API market. More people being diagnosed with liver disorders leads to an increased need for medical attention, which results in higher consumption of drugs based on ursodeoxycholic acid. This helps in the growth of the market.

2. Advancements in Pharmaceutical Manufacturing: Continuous manufacturing, streamlined purification processes, and other advanced manufacturing technologies are creating better and less expensive ursodeoxycholic acid APIs. Increased efficiency and scalability of production positively impact the market.

3. Support from the Government for Liver Disease Treatments: New treatments for liver disease, such as those which utilize ursodeoxycholic acid, are getting assistance from governments and regulatory bodies across the world. The growth of the ursodeoxycholic acid API market is driven by the quick approval processes and subsidies for liver disease therapies.

4. Greater Focus on Healthcare: Demand for medicines that use ursodeoxycholic acid is growing due to increased awareness of the treatment and prevention of liver disease. As people become more educated on maintaining their liver health, the willingness to seek medical attention rises, which benefits the ursodeoxycholic acid API market.

5. More Funding in R&D Activity: There is a large investment from within the pharmaceutical industry in research and development to find new therapeutic uses of ursodeoxycholic acid. The market is being expanded by this investment through the introduction of new indications and improvement of the effectiveness of the ursodeoxycholic acid-based treatments.

Challenges in the ursodeoxycholic acid API market are:

1. Barriers in Regulation: The multi-step and tedious regulatory approval process for new drugs, including those that are ursodeoxycholic acid-based, can be difficult for manufacturers to navigate. Regulatory hurdles tend to delay the introduction of new products into the market, which restricts growth.

2. Price Sensitivity in Emerging Markets: Growing price sensitivity in emerging markets poses a problem for ursodeoxycholic acid API manufacturers. The limited spending of healthcare systems in these parts of the world could make it difficult for manufacturers to profitably provide affordable ursodeoxycholic acid-based drugs.

3. Patent Expirations and Generic Competition: Generic manufacturers are increasingly competing with original developers due to the expiration of patents for ursodeoxycholic acid-based drugs. While this competition drives the price of ursodeoxycholic acid-based treatments down, it also makes it harder for original developers to retain their market share.

The market for ursodeoxycholic acid APIs is subjected to the increase in liver diseases, new technologies, favorable regulations, growth in healthcare awareness, and R&D spending, but also to the continuous regulatory burden in the United States, sensitivity to pricing, and competition from generic drugs. Manufacturers have to find ways to deal with these issues if market growth and other challenges are to be met successfully.

List of Ursodeoxycholic Acid API Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leveraging integration opportunities across the value chain. With these strategies, ursodeoxycholic acid API companies cater to increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the ursodeoxycholic acid API companies profiled in this report include:

• ICE
• Mitsubishi Tanabe Pharma
• Daewoong Chemical
• PharmaZell
• Zhongshan Bailing
• Dipharma Francis
• Grindeks

Ursodeoxycholic Acid API Market by Segment

The study includes a forecast for the global ursodeoxycholic acid API market by type, application, and region.

Ursodeoxycholic Acid API Market by Type [Value from 2019 to 2031]:

• Synthetic UDCA
• Extraction UDCA

Ursodeoxycholic Acid API Market by Application [Value from 2019 to 2031]:

• Pharmacy
• Health Products

Ursodeoxycholic Acid API Market by Region [Value from 2019 to 2031]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

Country Wise Outlook for the Ursodeoxycholic Acid API Market

This ursodeoxycholic acid API market is influenced by ongoing innovation in the pharmaceutical sector, growth in the liver disease treatment market, and increasing knowledge about the advantages of ursodeoxycholic acid. Some areas like the US, China, Germany, India, and Japan are showing marked changes in the ursodeoxycholic acid market. Improvement in manufacturing procedures, approved regulations, and growing numbers of clinical studies are factors contributing to growth in the market. A summary of the recent progress in the ursodeoxycholic acid API market of these countries is outlined below.

• United States: The United States is showing positive growth trends because of the growing number of liver diseases such as primary biliary cirrhosis (PBC). The demand for these drugs is increasing with the approval of ursodeoxycholic acid-based therapies for different liver disorders. Now, there is also an increasing emphasis on developing more sophisticated UCDA formulations. The quality and price of the APIs are also being enhanced by the manufacturers, resulting in better penetration of ursodeoxycholic acid-based therapies in the market. In addition, clinical research and trials are actively conducted in the area with encouraging results showing potential for treating other liver conditions, which is fueling market growth.
• China: Known for its unrivaled production capabilities and low-cost manufacturing, China has emerged as a world leader in the ursodeoxycholic acid API market. There is growing demand for ursodeoxycholic acid in China due to the improving healthcare system and increasing number of patients seeking treatment for liver diseases. The support by the Chinese government's policies for the pharmaceutical sector also greatly improves access to quality ursodeoxycholic acid APIs. Additionally, China's position in the ursodeoxycholic acid API market is being strengthened by the increasing number of clinical trials and research activities in the region, along with the adoption of new advanced manufacturing technologies.
• Germany: In Germany, the demand for ursodeoxycholic acid APIs is driven by advancements in the pharmaceutical sector. There is also a growing number of patients being diagnosed with liver diseases. The robust healthcare system in Germany, along with a high level of new drug utilization, drives the use of ursodeoxycholic acid medications. The German government also facilitates treatment innovation for liver diseases within the country. There is also an increase in R&D activities in Germany aimed at optimizing the ursodeoxycholic acid formulations and developing new therapeutic uses, and this is also contributing to market growth.
• India: The increasing demand for ursodeoxycholic acid APIs in India stems from both the growth of the healthcare sector and the rising cases of liver disorders in the country. There is ursodeoxycholic acid API production in India offered at competitive prices and of high quality to meet the global market demand. The Indian pharmaceutical industry is also funding R&D for enhanced formulations of ursodeoxycholic acid and other liver disease therapeutics. Growth in population awareness and the country's improved healthcare accessibility are further expected to drive the rise in ursodeoxycholic acid API sales in India.
• Japan: The ursodeoxycholic acid API market in Japan is continuously growing, which is largely attributed to the aging population and the high prevalence of liver diseases in the country. There is wide usage of ursodeoxycholic acid and cholic acid in Japan for liver disorder treatment, and the demand for better formulations is on the rise. Japanese pharmaceutical manufacturers are dedicated to using high-grade manufacturing equipment to produce superior quality ursodeoxycholic acid APIs in order to meet the stringent regulatory requirements in Japan. Moreover, the increase of Japan's investment into health R&D will most likely increase the use of ursodeoxycholic acid APIs, especially for chronic liver diseases.

Features of the Global Ursodeoxycholic Acid API Market

• Market Size Estimates: Ursodeoxycholic acid API market size estimation in terms of value ($B).
• Trend and Forecast Analysis: Market trends (2019 to 2024) and forecast (2025 to 2031) by various segments and regions.
• Segmentation Analysis: Ursodeoxycholic acid API market size by type, application, and region in terms of value ($B).
• Regional Analysis: Ursodeoxycholic acid API market breakdown by North America, Europe, Asia Pacific, and the Rest of the World.
• Growth Opportunities: Analysis of growth opportunities in different types, applications, and regions for the ursodeoxycholic acid API market.
• Strategic Analysis: This includes M&A, new product development, and the competitive landscape of the ursodeoxycholic acid API market.

Analysis of the competitive intensity of the industry based on Porter's Five Forces model.

This report answers the following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the ursodeoxycholic acid API market by type (synthetic UDCA and extraction UDCA), application (pharmacy and health products), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Market Overview

• 2.1 Background and Classifications
• 2.2 Supply Chain

3. Market Trends & Forecast Analysis

• 3.1 Macroeconomic Trends and Forecasts
• 3.2 Industry Drivers and Challenges
• 3.3 PESTLE Analysis
• 3.4 Patent Analysis
• 3.5 Regulatory Environment

4. Global Ursodeoxycholic Acid API Market by Type

• 4.1 Overview
• 4.2 Attractiveness Analysis by Type
• 4.3 Synthetic UDCA: Trends and Forecast (2019-2031)
• 4.4 Extraction UDCA: Trends and Forecast (2019-2031)

5. Global Ursodeoxycholic Acid API Market by Application

• 5.1 Overview
• 5.2 Attractiveness Analysis by Application
• 5.3 Pharmacy: Trends and Forecast (2019-2031)
• 5.4 Health Products: Trends and Forecast (2019-2031)

6. Regional Analysis

• 6.1 Overview
• 6.2 Global Ursodeoxycholic Acid API Market by Region

7. North American Ursodeoxycholic Acid API Market

• 7.1 Overview
• 7.2 North American Ursodeoxycholic Acid API Market by Type
• 7.3 North American Ursodeoxycholic Acid API Market by Application
• 7.4 United States Ursodeoxycholic Acid API Market
• 7.5 Mexican Ursodeoxycholic Acid API Market
• 7.6 Canadian Ursodeoxycholic Acid API Market

8. European Ursodeoxycholic Acid API Market

• 8.1 Overview
• 8.2 European Ursodeoxycholic Acid API Market by Type
• 8.3 European Ursodeoxycholic Acid API Market by Application
• 8.4 German Ursodeoxycholic Acid API Market
• 8.5 French Ursodeoxycholic Acid API Market
• 8.6 Spanish Ursodeoxycholic Acid API Market
• 8.7 Italian Ursodeoxycholic Acid API Market
• 8.8 United Kingdom Ursodeoxycholic Acid API Market

9. APAC Ursodeoxycholic Acid API Market

• 9.1 Overview
• 9.2 APAC Ursodeoxycholic Acid API Market by Type
• 9.3 APAC Ursodeoxycholic Acid API Market by Application
• 9.4 Japanese Ursodeoxycholic Acid API Market
• 9.5 Indian Ursodeoxycholic Acid API Market
• 9.6 Chinese Ursodeoxycholic Acid API Market
• 9.7 South Korean Ursodeoxycholic Acid API Market
• 9.8 Indonesian Ursodeoxycholic Acid API Market

10. ROW Ursodeoxycholic Acid API Market

• 10.1 Overview
• 10.2 ROW Ursodeoxycholic Acid API Market by Type
• 10.3 ROW Ursodeoxycholic Acid API Market by Application
• 10.4 Middle Eastern Ursodeoxycholic Acid API Market
• 10.5 South American Ursodeoxycholic Acid API Market
• 10.6 African Ursodeoxycholic Acid API Market

11. Competitor Analysis

• 11.1 Product Portfolio Analysis
• 11.2 Operational Integration
• 11.3 Porter's Five Forces Analysis
  • Competitive Rivalry
  • Bargaining Power of Buyers
  • Bargaining Power of Suppliers
  • Threat of Substitutes
  • Threat of New Entrants
• 11.4 Market Share Analysis

12. Opportunities & Strategic Analysis

• 12.1 Value Chain Analysis
• 12.2 Growth Opportunity Analysis
  • 12.2.1 Growth Opportunities by Type
  • 12.2.2 Growth Opportunities by Application
• 12.3 Emerging Trends in the Global Ursodeoxycholic Acid API Market
• 12.4 Strategic Analysis
  • 12.4.1 New Product Development
  • 12.4.2 Certification and Licensing
  • 12.4.3 Mergers, Acquisitions, Agreements, Collaborations, and Joint Ventures

13. Company Profiles of the Leading Players Across the Value Chain

• 13.1 Competitive Analysis
• 13.2 ICE
  • Company Overview
  • Ursodeoxycholic Acid API Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing
• 13.3 Mitsubishi Tanabe Pharma
  • Company Overview
  • Ursodeoxycholic Acid API Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing
• 13.4 Daewoong Chemical
  • Company Overview
  • Ursodeoxycholic Acid API Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing
• 13.5 PharmaZell
  • Company Overview
  • Ursodeoxycholic Acid API Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing
• 13.6 Zhongshan Bailing
  • Company Overview
  • Ursodeoxycholic Acid API Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing
• 13.7 Dipharma Francis
  • Company Overview
  • Ursodeoxycholic Acid API Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing
• 13.8 Grindeks
  • Company Overview
  • Ursodeoxycholic Acid API Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing

14. Appendix

• 14.1 List of Figures
• 14.2 List of Tables
• 14.3 Research Methodology
• 14.4 Disclaimer
• 14.5 Copyright
• 14.6 Abbreviations and Technical Units
• 14.7 About Us
• 14.8 Contact Us